Johnson & Johnson shares dipped slightly today, even as first-quarter earnings came in ahead of the consensus forecast. Shares of JNJ fell 1% to $145.16 apiece by mid-day trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell slightly. The New Brunswick, New Jersey-based medtech giant […]
Johnson & Johnson
J&J’s DePuy Synthes launches new spine screw system
Johnson & Johnson’s DePuy Synthes orthopedic unit today announced plans to showcase new advancements across its spine portfolio. The company plans to show the offerings at the 31st International Meeting on Advance Spine Techniques (IMAST) 2024 this week. Notably, the company plans to unveil its next-generation TriAltis spine system. The posterior thoracolumbar pedicle screw system […]
Biosense Webster reports positive dual-energy ablation results
Johnson & Johnson’s Biosense Webster unit today announced positive three-month follow-up results from its SmartfIRE clinical trial. The study evaluated the use of the dual-energy ThermoCool SmartTouch SF catheter. ThermoCool SmartTouch SF is the first dual-energy pulsed field ablation (PFA)/radiofrequency (RF) ablation catheter integrated with a PF and RF ablation index. Biosense Webster’s system in […]
Abiomed reports positive Impella CP results in treating cardiogenic shock
Johnson & Johnson’s Abiomed shared data supporting the use of its Impella CP in patients who had a heart attack with cardiogenic shock. The data was presented at the American College of Cardiology conference and published it in the New England Journal of Medicine. The study evaluated patients who had a heart attack with ST-elevation […]
FDA says recall of Cerenovus catheter guide sheaths is serious
The FDA deemed a recall of catheter guide sheaths from Johnson & Johnson’s Cerenovus Class I, the most serious kind. Medos International Sàrl, a J&J unit, recalled the Cerenovus Cerebase DA guide sheath and single-use neurovascular guide catheter on Feb. 2, 2024. The company distributed the devices — 1,343 in total — between June 14, […]
Johnson & Johnson to acquire Shockwave Medical for $13.1B
Johnson & Johnson announced today that it agreed to acquire Shockwave Medical (Nasdaq:SWAV) for approximately $13.1 billion. Media reports previously linked Johnson & Johnson with interest in buying the intravascular lithotripsy (IVL) technology maker last year. Suggestions of interest in a deal resurfaced just weeks ago and now the companies have reached an agreement. Under […]
Johnson & Johnson supports health equity initiative
Johnson & Johnson today announced its support for a collaboration with more than 100 community-led health organizations to improve health equity. The collaboration builds upon the company’s multiyear, multimillion-dollar efforts to improve health equity. Organizations involved support historically marignalized communities across the U.S., aiming to bridge the healthcare gap for people of color. “We recognize […]
Integra LifeSciences completes acquisition of J&J’s Acclarent
Integra LifeSciences announced that it completed its previously announced acquisition of Acclarent from Johnson & Johnson MedTech . Princeton, New Jersey-based Integra struck a deal with J&J to acquire Acclarent for $275 million upfront at the end of 2023. The deal also includes an additional $5 million upon the achievement of regulatory milestones. Acclarent, part […]
Shockwave Medical is reportedly a J&J acquisition target
Shockwave Medical could get acquired by Johnson & Johnson , according to a Wall Street Journal report. WSJ cited people familiar with the matter. They said the acquisition talks, if successful, could result in a finalized deal in the coming weeks. Another suitor could also seek a merger with Santa Clara, California–based Shockwave. The WSJ […]
J&J’s Biosense Webster submits Varipulse pulsed field ablation system for FDA approval
Johnson & Johnson MedTech’s Biosense Webster announced today that it submitted its Varipulse platform to the FDA for premarket approval. The company supported its PMA submission for the pulsed field ablation (PFA) system with results from the admIRE study. It aims to garner approval for the treatment of paroxysmal AFib. If approved, Varipulse would become […]
J&J’s Abiomed has a Class I Impella labeling recall with 49 deaths related to issue
The FDA deemed a recall of heart pumps from Johnson & Johnson MedTech’s (NYSE:JNJ) Abiomed Class I, the most serious kind. Abiomed reports 129 serious injuries, including 49 deaths, related to the issue of potential cuts in the wall of the heart. This recall (a correction and not a product removal) affects 66,390 Impella pumps […]